Nature Communications (Feb 2023)

Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation

  • Joshua M. Gammon,
  • Sean T. Carey,
  • Vikas Saxena,
  • Haleigh B. Eppler,
  • Shannon J. Tsai,
  • Christina Paluskievicz,
  • Yanbao Xiong,
  • Lushen Li,
  • Marian Ackun-Farmmer,
  • Lisa H. Tostanoski,
  • Emily A. Gosselin,
  • Alexis A. Yanes,
  • Xiangbin Zeng,
  • Robert S. Oakes,
  • Jonathan S. Bromberg,
  • Christopher M. Jewell

DOI
https://doi.org/10.1038/s41467-023-36225-5
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 18

Abstract

Read online

Antigen-specific tolerance represents a promising strategy to treat type 1 diabetes and islet allograft rejection. Here, the authors deliver immune signals to lymph nodes to promote antigen-specific regulatory T cells and prevent disease in models of type 1 diabetes and allogenic islet transplantation.